Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 66 Carcinoma, Renal Cell 38 Liver Neoplasms 20 Neoplasm Metastasis 17 Carcinoma, Non-Small-Cell Lung 16 Neoplasms 15 Breast Neoplasms 15 Melanoma 13 Thyroid Neoplasms 10 Leukemia, Myeloid, Acute 10 Sarcoma 9 Lung Neoplasms 8 Kidney Neoplasms 8 Prostatic Neoplasms 7 Ovarian Neoplasms 7 Urinary Bladder Neoplasms 6 Pancreatic Neoplasms 6 Glioblastoma 6 Brain Neoplasms 6 Colorectal Neoplasms 5 Carcinoma, Medullary 5 Thyroid Carcinoma, Anaplastic 4 Stomach Neoplasms 4 Rectal Neoplasms 4 Gliosarcoma 4 Gallbladder Neoplasms 4 Colonic Neoplasms 4 Breast Neoplasms, Male 4 Thyroid Diseases 3 Thyroid Cancer, Papillary 3

Interventions

pembrolizumab 6 Mitotane 5 Cisplatin 5 cabozantinib 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 sodium thiosulfate 2 relacorilant 2 cixutumumab 2 cemiplimab 2 camrelizumab 2 apatinib 2 Radiotherapy 2 Nivolumab 2 Ipilimumab 2 Etoposide 2 Cytoreduction Surgical Procedures 2 milademetan 1 lenvatinib 1 gossypol acetic acid 1 dostarlimab 1 cabazitaxel 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Vincristine 1 Tamoxifen 1 Suramin 1 Sunitinib 1 Sorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adrenocortical Carcinoma × Sorafenib × Clear all

NCT00786110 2009-02-24

PAXO

University of Turin, Italy

Phase 2 Unknown

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡